HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,019 | +5.2% | 123 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $10,473 | -5.6% | 123 | -8.2% | 0.00% | 0.0% |
| Q1 2023 | $11,089 | -46.0% | 134 | -48.7% | 0.00% | -50.0% |
| Q4 2022 | $20,528 | +105.3% | 261 | +94.8% | 0.00% | +100.0% |
| Q3 2022 | $10,000 | +11.1% | 134 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | +28.6% | 134 | +27.6% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | +133.3% | 105 | +64.1% | 0.00% | – |
| Q4 2021 | $3,000 | -66.7% | 64 | -48.0% | 0.00% | -100.0% |
| Q3 2021 | $9,000 | +50.0% | 123 | +46.4% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | 0.0% | 84 | +55.6% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | +20.0% | 54 | +28.6% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -42.9% | 42 | -47.5% | 0.00% | -50.0% |
| Q2 2020 | $7,000 | -85.7% | 80 | -83.6% | 0.00% | -75.0% |
| Q1 2020 | $49,000 | -3.9% | 488 | +5.9% | 0.01% | +33.3% |
| Q4 2019 | $51,000 | -10.5% | 461 | 0.0% | 0.01% | -33.3% |
| Q3 2019 | $57,000 | +5.6% | 461 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $54,000 | 0.0% | 461 | -28.7% | 0.01% | 0.0% |
| Q1 2019 | $54,000 | +671.4% | 647 | +708.8% | 0.01% | +350.0% |
| Q4 2018 | $7,000 | -12.5% | 80 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $8,000 | +33.3% | 80 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | +20.0% | 80 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | +25.0% | 80 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | +100.0% | 80 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $2,000 | – | 80 | +110.5% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 38 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 38 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $1,000 | -50.0% | 38 | -56.8% | 0.00% | 0.0% |
| Q3 2016 | $2,000 | +100.0% | 88 | +131.6% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | 0.0% | 38 | -9.5% | 0.00% | 0.0% |
| Q1 2016 | $1,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |